ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 82 filers reported holding ENZO BIOCHEM INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,387,000 | +11.1% | 170,144 | +42.7% | 1.33% | +13.7% |
Q3 2017 | $1,248,000 | -2.4% | 119,238 | +2.9% | 1.17% | -3.2% |
Q2 2017 | $1,279,000 | +1.8% | 115,878 | -22.7% | 1.21% | -5.1% |
Q1 2017 | $1,256,000 | +59.4% | 150,000 | +13.7% | 1.28% | -0.7% |
Q2 2016 | $788,000 | -59.3% | 131,956 | -69.0% | 1.28% | -51.8% |
Q1 2016 | $1,937,000 | -18.4% | 425,762 | -19.3% | 2.67% | +7.5% |
Q4 2015 | $2,373,000 | +13.5% | 527,274 | -20.1% | 2.48% | +10.4% |
Q3 2015 | $2,091,000 | +36.5% | 659,511 | +30.4% | 2.25% | +40.7% |
Q2 2015 | $1,532,000 | – | 505,583 | – | 1.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,620,681 | $20,234,000 | 30.10% |
Evermore Global Advisors, LLC | 4,007,851 | $14,428,000 | 3.48% |
Fondren Management LP | 355,000 | $1,278,000 | 1.06% |
CORRADO ADVISORS, LLC | 196,309 | $707,000 | 0.64% |
MARATHON CAPITAL MANAGEMENT | 193,580 | $697,000 | 0.28% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $344,000 | 0.23% |
EAM Investors, LLC | 203,962 | $734,000 | 0.19% |
Ariel Investments | 1,026,313 | $3,695,000 | 0.05% |
HighVista Strategies LLC | 19,500 | $70,000 | 0.05% |
Paradigm Financial Partners, LLC | 17,175 | $60,000 | 0.03% |